Faith E. Davies MD, FRCPath, MBBCh, MRCP

Faith E. Davies earned her medical degree from the University of Wales College of Medicine and completed her general medical training and hematology specialty training in the UK. Before joining the faculty of NYU Langone, New York, Dr. Davies held positions with the University of Arkansas for Medical Sciences, Arkansas, USA, and the Institute of Cancer Research / Royal Marsden Hospital, in London, UK.

Her research focus for three decades has been on the biology and treatment of plasma cell dyscrasias, in particular, the examination of potential new drugs and new genetic technologies. She is recognized internationally for her work looking at prognostic and predictive biomarkers (e.g, genetic abnormalities, imaging, and minimal residual disease) within the context of clinical trials.  Dr. Davies' laboratory work is aimed at identifying vulnerabilities in myeloma cells that may be exploited therapeutically and translating these findings into the clinical arena with a focus on individualized treatment.

Dr. Davies is an active member of the American Society of Hematology and the American Association for Cancer Research, and enjoys participating in several patient-focused organizations. She is widely published in leading peer-reviewed journals, including the New England Journal of Medicine, Lancet Oncology, Blood, Journal of Clinical Oncology, and Leukemia.